Nuveen LLC Invests $16.16 Million in Addus HomeCare Corporation $ADUS

Key Points

• Nuveen LLC has invested approximately $16.16 million in Addus HomeCare Corporation, acquiring 163,364 shares, which represents about 0.89% of the company.
• Several institutional investors, including King Luther Capital Management Corp and Cynosure Group LLC, significantly increased their stakes in Addus HomeCare during the first quarter.
• Addus HomeCare reported a $1.49 earnings per share for the last quarter, surpassing analyst estimates and showing a 21.8% increase in quarterly revenue compared to the previous year.

Nuveen LLC bought a new stake in Addus HomeCare Corporation (NASDAQ:ADUS - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 163,364 shares of the company's stock, valued at approximately $16,155,000. Nuveen LLC owned approximately 0.89% of Addus HomeCare as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently bought and sold shares of the company. Natixis lifted its stake in Addus HomeCare by 111.9% in the 4th quarter. Natixis now owns 250 shares of the company's stock valued at $31,000 after acquiring an additional 132 shares in the last quarter. Bailard Inc. bought a new stake in Addus HomeCare in the 1st quarter valued at approximately $208,000. Heritage Family Offices LLP lifted its stake in Addus HomeCare by 6.3% in the 1st quarter. Heritage Family Offices LLP now owns 2,417 shares of the company's stock valued at $239,000 after acquiring an additional 143 shares in the last quarter. Private Advisor Group LLC lifted its stake in Addus HomeCare by 52.4% in the 1st quarter. Private Advisor Group LLC now owns 2,546 shares of the company's stock valued at $252,000 after acquiring an additional 875 shares in the last quarter. Finally, Hohimer Wealth Management LLC raised its stake in shares of Addus HomeCare by 6.3% during the 1st quarter. Hohimer Wealth Management LLC now owns 2,561 shares of the company's stock worth $253,000 after purchasing an additional 152 shares in the last quarter. Institutional investors own 95.35% of the company's stock.

Wall Street Analyst Weigh In

ADUS has been the topic of a number of analyst reports. Macquarie reiterated an "outperform" rating and set a $133.00 price objective on shares of Addus HomeCare in a research note on Tuesday, June 10th. TD Cowen upped their price objective on Addus HomeCare from $135.00 to $139.00 and gave the stock a "buy" rating in a research note on Wednesday, August 6th. Barclays upped their price objective on Addus HomeCare from $83.00 to $109.00 and gave the stock an "underweight" rating in a research note on Tuesday, August 19th. JMP Securities reiterated a "market outperform" rating and set a $150.00 price objective on shares of Addus HomeCare in a research note on Wednesday, July 16th. Finally, Wall Street Zen upgraded Addus HomeCare from a "hold" rating to a "buy" rating in a research note on Sunday, June 29th. Two investment analysts have rated the stock with a Strong Buy rating, six have given a Buy rating and one has given a Sell rating to the company's stock. According to MarketBeat, the company has an average rating of "Buy" and an average price target of $138.38.

Insider Buying and Selling at Addus HomeCare

In other news, Director Veronica Hill-Milbourne sold 1,571 shares of the stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $114.93, for a total transaction of $180,555.03. Following the sale, the director directly owned 5,067 shares of the company's stock, valued at approximately $582,350.31. This represents a 23.67% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Brian Poff sold 7,739 shares of the stock in a transaction on Monday, August 25th. The stock was sold at an average price of $116.82, for a total value of $904,069.98. Following the sale, the executive vice president directly owned 56,980 shares in the company, valued at approximately $6,656,403.60. This trade represents a 11.96% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 34,310 shares of company stock valued at $3,958,375 in the last ninety days. 4.50% of the stock is currently owned by corporate insiders.

Addus HomeCare Stock Performance

NASDAQ ADUS traded down $2.50 on Tuesday, reaching $114.15. The stock had a trading volume of 102,299 shares, compared to its average volume of 203,027. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.74 and a quick ratio of 1.74. The firm has a fifty day moving average of $112.02 and a two-hundred day moving average of $106.95. Addus HomeCare Corporation has a 1-year low of $88.96 and a 1-year high of $136.72. The company has a market cap of $2.10 billion, a P/E ratio of 25.20, a price-to-earnings-growth ratio of 1.78 and a beta of 0.80.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last issued its quarterly earnings data on Monday, August 4th. The company reported $1.49 EPS for the quarter, beating analysts' consensus estimates of $1.45 by $0.04. Addus HomeCare had a return on equity of 9.39% and a net margin of 6.51%.The firm had revenue of $349.44 million for the quarter, compared to analyst estimates of $345.71 million. During the same period in the prior year, the firm posted $1.35 EPS. The company's revenue for the quarter was up 21.8% on a year-over-year basis. On average, equities research analysts anticipate that Addus HomeCare Corporation will post 4.59 EPS for the current year.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.